GlassScriptPhysician profile
Christopher Buckingham Ballou
NPI 1659400943
$1,473.48
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2020: $489 · 2022: $21.67.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $327.38 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $243.94 | 2019-2020 | |
| Amgen INC. | $115.14 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $97.78 | 2019-2020 | |
| Ethicon US, LLC | $95.39 | 2019 | |
| Pfizer INC. | $92.96 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.59 | 2019-2020 | |
| Allergan, INC. | $64.78 | 2019-2020 | |
| Amarin Pharma, INC. | $30.96 | 2019-2020 | |
| Abbott Laboratories | $30.56 | 2019-2020 | |
| Astellas Pharma US INC | $27.98 | 2019 | |
| Merck Sharp & Dohme LLC | $24.87 | 2019-2020 | |
| Radius Health, INC. | $24.54 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.16 | 2019-2020 | |
| Boston Scientific Corporation | $21.67 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $19.89 | 2020 | |
| Sanofi Pasteur INC. | $15.61 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.52 | 2019 | |
| Shire North American Group INC | $14.76 | 2019 | |
| Nestle Healthcare Nutrition INC. | $14.61 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.37 | 2019 | |
| Mylan Specialty L.P. | $13.36 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.71 | 2019 | |
| Lilly USA, LLC | $11.78 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.49 | 2020 | |
| Hikma Pharmaceuticals USA | $11.35 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.33 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ballou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.